A Phase 1b/2, Open-label, Global, Multicenter, Dose Determination Study to Evaluate Safety, Tolerability, and Preliminary Efficacy of CC-486 (ONUREG®) in Combination Therapy in Subjects with Acute Myeloid Leukemia (AML)

  • Wei, Andrew (Primary Chief Investigator (PCI))
  • Kennedy, Nola (Project Manager)

Project: Research

Project Details

Effective start/end date9/09/2131/12/25


  • Acute Myeloid Leukaemia (AML)
  • Malignant Haematology
  • Clinical trial